BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Gargan S, Lu Y, Stevenson NJ. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. Viruses 2021;13:560. [PMID: 33810391 DOI: 10.3390/v13040560] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Michel HA, Wang P, Smith GL. Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1027015] [Reference Citation Analysis]
2 Peters MH. Flap structure within receptor binding domain of SARS-CoV-2 spike periodically obstructs hACE2 Binding subdomain bearing similarities to HIV-1 protease flap. Sci Rep 2022;12:16236. [PMID: 36171252 DOI: 10.1038/s41598-022-20656-z] [Reference Citation Analysis]
3 Zhang Y, Gargan S, Roche FM, Frieman M, Stevenson NJ. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells. Viruses 2022;14:667. [PMID: 35458397 DOI: 10.3390/v14040667] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bauer W, Weber M, Diehl-wiesenecker E, Galtung N, Prpic M, Somasundaram R, Tauber R, Schwenk JM, Micke P, Kappert K. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection. Viruses 2021;13:2456. [DOI: 10.3390/v13122456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Arcanjo A, Pinto KG, Logullo J, Leite PEC, Menezes CCB, Freire-de-Lima L, Diniz-Lima I, Decoté-Ricardo D, Rodrigues-da-Silva RN, Freire-de-Lima CG, Filardy AA, Lima-Junior JDC, Bertho AL, De Luca PM, Granjeiro JM, Barroso SPC, Conceição-Silva F, Savino W, Morrot A. Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection. J Infect Dis 2021:jiab425. [PMID: 34427670 DOI: 10.1093/infdis/jiab425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Zandi M, Soltani S. Severe acute respiratory syndrome coronavirus-2 and its structural proteins. J Cell Physiol 2021. [PMID: 34352115 DOI: 10.1002/jcp.30546] [Reference Citation Analysis]
7 Jin T, Xu Y, Dai C, Zhou X, Xu Q, Wu Z. Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission. AIP Adv 2021;11:085019. [PMID: 34413992 DOI: 10.1063/5.0060530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wang B, Svetlov V, Wolf YI, Koonin EV, Nudler E, Artsimovitch I. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides. mBio 2021;12:e0142321. [PMID: 34154407 DOI: 10.1128/mBio.01423-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
9 Chan S, Shafi T, Ford RC. Kite-shaped molecules block SARS-CoV-2 cell entry at a post-attachment step.. [DOI: 10.1101/2021.05.29.446272] [Reference Citation Analysis]
10 Buesa J. Grand Challenge in Viral Disease Investigation: An Endless Endeavor. Front Virol 2021;1. [DOI: 10.3389/fviro.2021.692105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang B, Svetlov V, Wolf YI, Koonin EV, Nudler E, Artsimovitch I. Allosteric activation of SARS-CoV-2 RdRp by remdesivir triphosphate and other phosphorylated nucleotides. bioRxiv 2021:2021. [PMID: 33948598 DOI: 10.1101/2021.01.24.428004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]